Eating disorders: neurologic manifestations …

Neeraj Kumar MD

General Neurology

Updated 06.25.2023
Released 08.28.2000
Expires For CME 06.25.2026

Eating disorders: neurologic manifestations

Author: Neeraj Kumar MD

See Contributor Disclosures

Editor: Amy A Pruitt MD

Eating disorders: neurologic manifestations

In This Article

Quick Link

Introduction

Overview

The hallmark of eating disorders is abnormal eating patterns or weight control behaviors. Excessive focus on and altered perception of body shape and weight is integral to these disorders. Eating disorders are associated with disrupted psychosocial functioning and impaired physical health, including neurologic complications (05; 10; 68).

Historical note and terminology

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) recognizes six feeding and eating disorders: those that were included in DSM-IV include anorexia nervosa, bulimia nervosa, and binge eating disorder; the three disorders added in DSM-5 were avoidant-restrictive food intake disorder, pica, and rumination disorder (Tables 1 to 6) (05). With the exception of pica, at a specific point in time only one of these diagnoses can be assigned, emphasizing the mutually exclusive nature of this classification scheme.

Historical accounts have revealed that forms of voluntary self-starvation have existed for thousands of years. It was not until 1873, however, that Gull and Lasegue presented complete medical descriptions of anorexia nervosa, leading to the disorder being accepted as a true disorder in the late 1800s (18; 35; 09). Binge eating disorder was first recognized in 1959 in a paper written by Albert Stunkard (63). He had associated eating episodes with night-time eating, but the term is now used irrespective of the timing of excessive eating. Until recently, boys and men had been historically underrepresented in eating disorder research (11). Additionally, studies have highlighted the global nature of the high prevalence of eating disorders (57).

Clinical manifestations

Presentation and course

Eating disorders involve serious disturbances in eating behavior such as extreme reduction of food intake or severe overeating, as well as feelings of distress or extreme concern about body shape or weight (10; 68; 72; 43). These disorders usually begin with a prepubertal preoccupation with body image and an intense fear of being overweight. This stage is followed by intense dieting during adolescence and during the normal body shape changes that accompany it. As dieting becomes a perceived tool for controlling weight, disordered eating or chronic dieting is a frequent result. Patients often count calories, participate in activities that promote weight loss such as ballet or wrestling, and may have been witnessed vomiting.

Anorexia nervosa. Anorexia nervosa is characterized by an intense fear of weight gain, often associated with a disturbance in body image perception (Table 1) (67; 68; 76; 50). This prompts severe dietary restriction including fasting or other weight loss behaviors like purging or excessive physical activity. Medical complications of anorexia nervosa can affect all systems and are commonly due to malnutrition (17). Anorexia nervosa is further subdivided into the restricting or binge-eating/purging subtypes (05).

Severe emaciation may be accompanied by hypotension, bradycardia, and hypothermia. The skin may be dry and scaly. Hair loss, brittle hair, or fine downy body hair (lanugo) may be present. Dental erosions may be present. Additional features include delayed puberty, amenorrhea, infertility, arrested growth, and osteopenia or osteoporosis. Gastrointestinal manifestations include prolonged gastrointestinal transit and constipation. Neurologic complications in anorexia nervosa are primarily due to malnutrition and deficiency of specific nutrients and are discussed below.

Bulimia nervosa. Bulimia nervosa is characterized by repeated episodes of binge eating with compensatory behaviors to prevent weight gain like self-induced vomiting, fasting, extreme exercise, or inappropriate use of medications like diuretics and laxatives (74; 68) (Table 2). Body shape, weight, and appearance influence negative self-evaluation. Bulimia nervosa can occur at normal or elevated weight.

Physical findings in bulimia nervosa are less severe than those in anorexia nervosa; specific problems related to purging may include cardiac arrhythmias, electrolyte disturbances, metabolic acidosis due to laxative use, alkalosis due to vomiting, esophageal or gastric erosions or perforation, dental erosions, and acute renal injury.

Binge eating disorder. Recurrent episodes of binge eating are the hallmark of binge eating disorder (31; 21; 32; 23; 68) (Table 3). Both bulimia and binge eating disorder can be associated with obesity; compensatory behaviors are less common in binge eating disorder as compared to bulimia nervosa.

Avoidant-restrictive food intake disorder. Avoidant-restrictive food intake disorder is characterized by avoidance or restriction of food intake (15; 68) (Table 4). Milder cases may come across as being picky eaters. Additional symptoms include weight loss, nutritional deficiencies, dependence on enteral feeding or nutritional supplements, and psychosocial impairment. Patients may fear eating due to prior experiences like choking or vomiting, They may demonstrate extreme food selectivity, or have a lack of interest in food and eating.

Pica. Pica is characterized by intake of non-food or non-nutritive substances (20; 68) (Table 5). Boredom, curiosity, psychological stress, or taste of the substance being ingested are the primary triggers.

Rumination disorder. Rumination involves regurgitation of food after eating (68) (Table 6). Nausea or retching are not seen and a medical cause needs to be ruled out.

Psychiatric and neurologic comorbidities are commonly seen in patients with eating disorders and include mood and anxiety disorders, attention deficit hyperactivity disorder, personality disorders, neurodevelopmental disorders including intellectual disability and autism, and substance abuse (52; 61; 59; 69; 68).

Additionally, DSM-5 contains two additional categories: other specified feeding and eating disorders that includes atypical anorexia nervosa, bulimia nervosa or binge-eating disorder of low frequency and/or limited duration, purging disorder, and night eating syndrome. Another category called “others” includes muscle dysmorphia (body dysmorphic disorder) and orthorexia nervosa (obsession with healthy eating that can be associated with restrictive eating behaviors and malnutrition risk).

Table 1. DSM-IV-TR Diagnostic Criteria for Anorexia Nervosa

	(A) Restriction of energy intake relative to requirements, leading to a significantly low body weight in the context of age, sex, developmental trajectory, and physical health. Significantly low weight is defined as a weight that is less than minimally normal or, for children and adolescents, less than that minimally expected.
	(B) Intense fear of gaining weight or of becoming fat, or persistent behavior that interferes with weight gain, even though at a significantly low weight.
	(C) Disturbance in the way in which one’s body weight or shape is experienced, undue influence of body weight or shape on self-evaluation, or persistent lack of recognition of the seriousness of the current low body weight.
Specify whether:
	Restricting type: During the last 3 months, the individual has not engaged in recurrent episodes of binge eating or purging behavior (ie, self-induced vomiting or the misuse of laxatives, diuretics, or enemas). This subtype describes presentations in which weight loss is accomplished primarily through dieting, fasting, and/or excessive exercise.
	Binge-eating/purging type: During the last 3 months, the individual has engaged in recurrent episodes of binge eating or purging behavior (ie, self-induced vomiting or the misuse of laxatives, diuretics, or enemas).
Specify if:
	• In partial remission: After full criteria for anorexia nervosa were previously met, criterion A (low body weight) has not been met for a sustained period, but either criterion B (intense fear of gaining weight or becoming fat or behavior that interferes with weight gain) or criterion C (disturbances in self-perception of weight and shape) is still met.
	• In full remission: After full criteria for anorexia nervosa were previously met, none of the criteria have been met for a sustained period of time.
Specify current severity:
	The minimum level of severity is based, for adults, on current body mass index (BMI) (see below) or, for children and adolescents, on BMI percentile. The ranges below are derived from World Health Organization categories for thinness in adults; for children and adolescents, corresponding BMI percentiles should be used. The level of severity may be increased to reflect clinical symptoms, the degree of functional disability, and the need for supervision. • Mild: BMI ≥ 17 kg/m2 • Moderate: BMI 16 to 16.99 kg/m2 • Severe: BMI 15 to 15.99 kg/m2 • Extreme: BMI < 15 kg/m2

Table 2. DSM-5 Diagnostic Criteria for Bulimia Nervosa

	(A) Recurrent episodes of binge eating. An episode of binge eating is characterized by both of the following:
		1. Eating, in a discrete period of time (eg, within any 2-hour period), an amount of food that is definitely larger than most people would eat during a similar period of time and under similar circumstances. 2. A sense of lack of control over eating during the episode (eg, feeling that one cannot stop eating or control what or how much one is eating).
	(B) Recurrent inappropriate compensatory behaviors in order to prevent weight gain, such as self-induced vomiting; misuse of laxatives, diuretics, or other medications; fasting; or excessive exercise. (C) The binge eating and inappropriate compensatory behaviors both occur, on average, at least once a week for 3 months. (D) Self-evaluation is unduly influenced by body shape and weight. (E) The disturbance does not occur exclusively during episodes of anorexia nervosa.
Specify if:
	• In partial remission: After full criteria for bulimia nervosa were previously met, some, but not all, of the criteria have been met for a sustained period of time. In full remission: After full criteria for bulimia nervosa were previously met, none of the criteria have been met for a sustained period of time.
Specify current severity:
	The minimum level of severity is based on the frequency of inappropriate compensatory behaviors (see below). The level of severity may be increased to reflect other symptoms and the degree of functional disability. • Mild: An average of 1 to 3 episodes of inappropriate compensatory behaviors per week. • Moderate: An average of 4 to 7 episodes of inappropriate compensatory behaviors per week. • Severe: An average of 8 to 13 episodes of inappropriate compensatory behaviors per week. • Extreme: An average of 14 or more episodes of inappropriate compensatory behaviors per week.

Table 3. DSM-5 Diagnostic Criteria for Binge-Eating Disorder

	(A) Recurrent episodes of binge eating. An episode of binge eating is characterized by both of the following:
		1. Eating, in a discrete period of time (eg, within any 2-hour period), an amount of food that is definitely larger than what most people would eat in a similar period of time under similar circumstances.
		2. A sense of lack of control over eating during the episode (eg, a feeling that one cannot stop eating or control what or how much one is eating).
	(B) The binge-eating episodes are associated with 3 (or more) of the following:
		1. Eating much more rapidly than normal.
		2. Eating until feeling uncomfortably full.
		3. Eating large amounts of food when not feeling physically hungry.
		4. Eating alone because of feeling embarrassed by how much one is eating.
		5. Feeling disgusted with oneself, depressed, or very guilty afterward.
	(C) Marked distress regarding binge eating is present.
	(D) The binge eating occurs, on average, at least once a week for 3 months
	(E) The binge eating is not associated with the recurrent use of inappropriate compensatory behavior as in bulimia nervosa and does not occur exclusively during the course of bulimia nervosa or anorexia nervosa.
Specify if:
	• In partial remission: After full criteria for binge-eating disorder were previously met, binge eating occurs at an average frequency of less than 1 episode per week for a sustained period of time.
	• In full remission: After full criteria for binge-eating disorder were previously met, none of the criteria have been met for a sustained period of time.
Specify current severity:
	The minimum level of severity is based on the frequency of episodes of binge eating (see below). The level of severity may be increased to reflect other symptoms and the degree of functional disability. • Mild: 1 to 3 binge-eating episodes per week • Moderate: 4 to 7 binge-eating episodes per week • Severe: 8 to 13 binge-eating episodes per week • Extreme: 14 or more binge-eating episodes per week

Table 4. DSM-5 Diagnostic Criteria for Avoidant-Restrictive Food Intake Disorder

	(A) An eating or feeding disturbance (eg, apparent lack of interest in eating or food, avoidance based on the sensory characteristics of food, concern about aversive consequences of eating) associated with one (or more) of the following:
		1. Significant weight loss (or failure to achieve expected weight gain or faltering growth in children)
		2. Significant nutritional deficiency
		3. Dependence on enteral feeding or oral nutritional supplements
		4. Marked interference with psychosocial functioning
	(B) The disturbance is not better explained by lack of available food or by an associated culturally sanctioned practice.
	(C) The eating disturbance does not occur exclusively during the course of anorexia nervosa or bulimia nervosa, and there is no evidence of a disturbance in the way in which one’s body weight or shape is experienced.
	(D) The eating disturbance is not attributable to a concurrent medical condition or not better explained by another mental disorder. When the eating disturbance occurs in the context of another condition or disorder, the severity of the eating disturbance exceeds that routinely associated with the condition or disorder and warrants additional clinical attention.
Specify if:
	• In remission: After full criteria for avoidant/restrictive food intake disorder were previously met, the criteria have not been met for a sustained period of time.

Table 5. DSM-5 Diagnostic Criteria for Pica

	(A) Persistent eating of nonnutritive, nonfood substances over a period of at least 1 month.
	(B) The eating of nonnutritive, nonfood substances is inappropriate to the developmental level of the individual.
	(C) The eating behavior is not part of a culturally supported or socially normative practice.
	(D) If the eating behavior occurs in the context of another mental disorder (eg, intellectual disability or intellectual developmental disorder, autism spectrum disorder, schizophrenia) or medical condition (including pregnancy), it is sufficiently severe to warrant additional clinical attention.
Specify if:
	• In remission: After full criteria for pica were previously met, the criteria have not been met for a sustained period of time.

Table 6. DSM-5 Diagnostic Criteria for Rumination Disorder

	(A) Repeated regurgitation of food over a period of at least 1 month. Regurgitated food may be re-chewed, re-swallowed, or spit out.
	(B) The repeated regurgitation is not attributable to an associated gastrointestinal or other medical condition (eg, gastroesophageal reflux, pyloric stenosis).
	(C) The eating disturbance does not occur exclusively during the course of anorexia nervosa, bulimia nervosa, binge-eating disorder, or avoidant/restrictive food intake disorder.
	(D) If the symptoms occur in the context of another mental disorder (intellectual disability [intellectual developmental disorder] or another neurodevelopmental disorder), they are sufficiently severe to warrant additional clinical attention.
Specify if:
	• In remission: After full criteria for rumination disorder were previously met, the criteria have not been met for a sustained period of time.

Neurologic complications. Of all the eating disorders, anorexia nervosa and bulimia nervosa in particular can cause significant medical complications (53; 54; 28). Neurologic complications when present are generally the direct result of malnutrition (Table 7) (34).

Table 7. Neurologic Dysfunction in Eating Disorders

Peripheral nervous system and muscle
	• Peripheral neuropathy (including compression neuropathies) • Myopathy
Central nervous system
	• Cerebral or cerebellar atrophy • Limbic system dysfunction • Osmotic demyelination disorder • Neuroendocrine dysregulation • Wernicke-Korsakoff syndrome • Marchiafava-Bignami disease

Peripheral neuropathic and muscle disease. In reviewing records of 100 patients with anorexia nervosa, Patchell and colleagues found that neuromuscular abnormalities were the most common type of neurologic complication, being present in 45% of the patients. Generalized muscle weakness was detected in 43% of the patients and peripheral neuropathies in 13%. Only one patient had symptoms directly attributable to a vitamin B12 deficiency, and in most patients, the neurologic complications were reversed completely after correction of nutritional deficiencies and fluid and electrolyte imbalances (54).

One prospective controlled study of 51 patients with anorexia nervosa found that peripheral neuropathy is a notable complication of anorexia nervosa and is thought to be a product of chronic malnutrition rather than a specific nutrient deficiency (41). Micronutrient status is commonly altered in anorexia nervosa (02). Vitamin B deficiency, in particular vitamin B12, vitamin B1 (thiamine), vitamin B9 (folic acid), and vitamin B6 (pyridoxine) can cause peripheral neuropathy (34). Nutritional causes of neuropathy also include copper and vitamin E deficiency, though copper deficiency typically causes a myeloneuropathy and vitamin E deficiency is associated with a neuronopathy and often has a spinocerebellar presentation (34).

Patients with anorexia nervosa also appeared to be at increased risk for developing localized compression neuropathies secondary to subcutaneous tissue loss (41). Peroneal nerve palsy is the best characterized compression neuropathy and is thought to be due to a loss of tissue around the head of the fibula, which makes the peroneal nerve more susceptible to the direct pressure of crossed legs. This direct pressure can cause both focal demyelination and axonal loss. Given the absence of generalized neuropathy in these cases, concomitant nutrient deficiency is unlikely to have been the primary cause of the peroneal nerve palsy (30; 40). Two case reports by Alloway and colleagues describe neuromyopathy with severe wasting and asymmetrical weakness of proximal limb muscles (04). Both of these patients made complete recoveries on a mixed diet. Structural and functional changes in skeletal muscle in eight patients with anorexia nervosa were recorded by McLoughlin and colleagues (42). They found that protein-energy malnutrition lead to metabolic myopathy that could be successfully treated with an appropriate refeeding program.

Central nervous system disease.

Cerebral atrophy and functional brain changes. Multiple studies have shown that patients with anorexia nervosa have reduced brain mass (75). These include postmortem studies that showed reduced cerebral mass with prominent sulci and small gyri, CT neuroimaging studies that have additionally shown enlarged ventricles, and MRI studies that have shown large CSF volumes in association with deficits in total gray matter and total white matter volumes as well as enlarged ventricles. These abnormalities are less pronounced in individuals with bulimia nervosa.

A study by Wagner and colleagues, which examined 40 patients recovered from anorexia nervosa as well as 10 patients recovered from bulimia nervosa, suggests that these structural brain abnormalities may be reversible after long-term recovery from the eating disorder (75). It is thought that the degree of recovery from an eating disorder may be critical for normalization of brain morphometry. Although emaciation and malnutrition are known to be associated with altered brain morphology abnormalities in anorexia nervosa, the physiology underlying changes in the brain structure remains elusive. Because the abnormalities are reversible, it is thought that they may be related to fluid shifts that are perhaps caused by altered hormonal function. Cortisol levels and triiodothyronine levels have been studied and found to be correlated to CSF volumes and ventricular size, respectively. It is also thought that decreased serum proteins may result in decreased colloidal osmotic pressure and a resultant shift of fluid from the intravascular space into the subarachnoid spaces.

In an attempt to identify brain regions critically involved in the pathophysiology of anorexia nervosa, Muhlau and colleagues applied voxel-based morphometry in recovered anorexia nervosa patients compared to controls (48). They found that gray matter was significantly decreased across the whole brain in the anorexia nervosa group, and only one small cluster of gray matter loss was identified, within the left anterior cingulate cortex. The severity of anorexia nervosa was the only clinical variable that correlated with the gray matter content of the anterior cingulate cortex cluster. The relevance of this is not yet fully understood.

Although neuroanatomical abnormalities often correct in weight-restored anorectic individuals, specific functions in certain cortical areas fail to correct in these patients, suggesting trait-related abnormalities. For example, reduced 5-HT2A receptor binding has been found to remain after long-term weight restoration in patients with anorexia nervosa. In individuals with bulimia nervosa, thalamic and hypothalamic serotonin transporter availability is reduced in relation to the duration of the bulimia nervosa (62). Studies that used single positron emission computed tomography in patients with anorexia nervosa showed hypoperfusion in the medial prefrontal cortex and anterior cingulated cortex even after weight restoration (64). Using functional magnetic resonance imaging, patients with recovered anorexia nervosa compared to controls had increased medial prefrontal and anterior cingulate cortex activation as well as lack of activity in the inferior parietal lobule (71). Chronically ill patients showed increased activation of the right lateral prefrontal, frontopolar, and dorsal anterior cingulated cortices. Additionally, asymmetric functional deficits have been found in women with anorexia nervosa and bulimia nervosa, which supports the hypothesis that anorexia nervosa involves specific left hemisphere dysfunction and bulimia nervosa involves specific right hemispheric dysfunction (16).

Cerebellar atrophy. At least two cases of cerebellar atrophy have been reported in the literature, with one patient displaying marked cerebellar ataxia (03; 45). Although the exact relationships between eating disorders and cerebellar atrophy are not clear, it is possible that the atrophy may be induced by life-threatening undernutrition. The reversibility of the cerebellar atrophy has not been determined.

Limbic system dysfunction. Some functional neuroimaging studies in patients with early-onset (onset in individuals younger than 15 years) anorexia nervosa have shown unilateral reduction of blood flow in the temporal region and impaired visuospatial ability, impaired visual memory, and enhanced speed of information processing (36). The reduced regional cerebral blood flow is noted to persist independently of variables such as previous or current nutritional status as well as eating disorder psychopathology so that the hypoperfusion is thought to be either a primary phenomenon or a result of starvation that is slow to reverse or is irreversible. It is thought that the system most likely to account for the characteristic features of anorexia nervosa as well as reduced blood flow and impaired cognitive functioning is the limbic system. Lask and colleagues hypothesize that limbic system dysfunction in anorexia nervosa might emerge as a final pathway of interactions between predisposing and precipitating factors, though clearly further research is required to test these hypotheses (36).

Osmotic demyelination disorder. Patients with eating disorders may attempt weight loss through vomiting, polydipsia, and laxative and/or diuretic abuse. These behaviors can lead to hyponatremia and/or hypokalemia. Hyponatremia when rapidly corrected can lead to rapid shifts in plasma osmolality with disruption of myelin (osmotic demyelination disorder). Pontine or extrapontine myelinolysis have been described in patients with eating disorders (58). Sites involved on MRI may include the pons, mesencephalon, caudate, putamen, globus pallidus, and centrum semiovale. Symptoms resulting during osmotic demyelination disorder have been reported to include agitation, emotional lability, tremulousness, dystonia, gait ataxia, quadriparesis, locked-in syndrome, encephalopathy, dysarthria, dysphagia, and bradykinesia.

Neuroendocrine dysregulation. It is still not clear what comes first, neuroendocrine alterations that could represent pathogenetic causes of eating disorders or eating disorder psychopathology that results in nutritional impairment and, as a result, neuroendocrine changes (47). Either way, changes are seen in multiple hormones and peptides, including leptin, ghrelin, brain-derived neurotrophic growth factor, and endocannabinoids. These changes likely occur to signal to the brain that a more energy-saving metabolic state and increased caloric ingestion are needed. In addition to modulating food intake, some of these compounds intervene in the regulation of psychological dimensions that are altered in anorexia nervosa and bulimia nervosa. Most of the neuroendocrine changes are state dependent, but some do persist after recovery from the eating disorder, especially if the recovery is not to full body weight. These persistent changes may then make relapse or recurrence more likely to occur (47).

Refeeding syndrome. Studies have shown that over one quarter of adolescents with anorexia nervosa hospitalized for malnutrition experience mild to moderate hypophosphatemia during refeeding. This can lead to muscle weakness, acute areflexic paralysis, paraesthesias, and cranial nerve palsies, all thought to be owing to tissue hypoxia. Hypophosphatemia may also cause seizures, coma, and mental status changes including delirium (22).

Wernicke encephalopathy. Wernicke encephalopathy is an acute neuropsychiatric syndrome due to thiamine deficiency that is characterized by mental status changes, gait ataxia, and ophthalmoplegia (56; 34). As the encephalopathy resolves, an amnestic confabulatory syndrome called Korsakoff psychosis evolves. It has classically been described in the setting of alcoholism but can be seen in many different settings including anorexia-nervosa-related malnutrition (56).

Marchiafava-Bignami disease. Marchiafava-Bignami disease is a rare disorder characterized by demyelination involving the corpus callosum and is typically seen in the setting of chronic alcoholism. It has rarely been described in association with other conditions like malnutrition, including anorexia nervosa-related malnutrition (65).

Prognosis and complications

It is estimated that nearly one half of patients with anorexia nervosa recover, 33% improve somewhat, and 20% remain chronically ill. Similar to anorexia nervosa, approximately 50% of patients with bulimia nervosa recover, 30% improve somewhat, and 20% continue to meet full diagnostic criteria for bulimia nervosa. Long-term follow-up studies suggest that only 10% of bulimic individuals continue to fully meet diagnostic criteria after 10 years of the illness (01).

Mortality rates for anorexia nervosa and bulimia nervosa are the highest in psychiatric conditions and amongst the highest in medical conditions (10). Mortality from anorexia nervosa has been estimated to be 5% per decade which is about 12 times higher than the annual death rate due to all causes of death among females ages 15 to 24 in the general population. The most common causes of death are complications of the disorder, such as cardiac arrest or electrolyte imbalance, and suicide (51).

The prognosis of any neurologic event occurring in the setting of an eating disorder depends on the specific clinical situation and etiology of the process in question. Many symptoms resolve with re-establishment of proper nutrition. Refeeding needs to be done with care and in a controlled setting to avoid the neurologic complications associated with hypophosphatemia.

Diagnostic workup

A broad range of laboratory abnormalities can be seen due to starvation or purging (55; 10; 68). This is particularly so in anorexia nervosa. Laboratory abnormalities could include anemia, leukopenia, thrombocytopenia, hypoglycemia, elevated liver enzymes, hypothyroidism, low levels of estrogen or testosterone, elevated levels of corticotrophin-releasing hormone and growth hormone, and elevated salivary amylase due to vomiting. Purging can result in hypokalemic alkalosis. Laxative use may result in metabolic acidosis. Dehydration can result in acute kidney injury. Electrolyte abnormalities hypokalemia and hypophosphatemia can result in electrocardiographic abnormalities. Hyponatremia may also be seen.

The diagnostic workup for any neurologic complication of an eating disorder depends on the type of neurologic process present and the clinical situation. The goal of each workup is to confirm the presence of the specific problem and to exclude other processes that may be co-occurring with, but are independent from, the eating disorder itself. It is important to remember that neurologic complications related to thiamine deficiency in anorexia nervosa can be present despite normal serum thiamine levels (56; 34).

If peripheral nerve involvement is suspected, EMG and nerve conduction velocity studies can be performed and additional laboratories obtained as would be done for any routine peripheral neuropathy evaluation. It is important to remember the potential for electrolyte abnormalities and nutritional deficits in individuals with eating disorders. If the clinical presentation suggests muscle involvement, EMG and nerve conduction velocity can be obtained. Additional laboratory studies such as muscle enzymes and erythrocyte sedimentation rate can also be useful. Muscle biopsy may be performed but is rarely recommended as myopathy in eating disorders is treated by simply instituting an appropriate refeeding program (42).

MRI of the brain or spinal cord may show specific findings in vitamin B12 or copper deficiency and in Wernicke-Korsakoff syndrome (34). In a patient presenting with a seizure or encephalopathy, a structural lesion should be excluded with appropriate neuroimaging and an electroencephalogram should also be obtained. Metabolic and/or nutritional derangements (especially hypophosphatemia) must be sought with appropriate laboratory testing.

References

01: Academy for Eating Disorders. Academy for Eating Disorders website, available at www.aedweb.org. 2007.
02: Achamrah N, Coeffier M, Rimbert A, et al. Micronutrient status in 153 patients with anorexia nervosa. Nutrients 2017;9(3):225. PMID 28257095
03: Addolorato G, Taranto C, Capristo E, Gasbarrini G. A case of marked cerebellar atrophy in a woman with anorexia nervosa and cerebral atrophy and a review of the literature. Int J Eat Disord 1998;24(4):443-7. PMID 9813771
04: Alloway R, Reynolds EH, Spargo E, Russell GF. Neuropathy and myopathy in two patients with anorexia and bulimia nervosa. J Neurol Neurosurg Psychiatry 1985;48(10):1015-20. PMID 3863893
05: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edition. Washington, DC: American Psychiatric Association Press, 2013.
06: American Psychiatric Association Practice Guidelines. Treatment of Patients with Eating Disorders. 3rd edition. Washington, DC: American Psychiatric Association Press, 2006.
07: American Psychiatric Association Practice Guidelines. Guideline Watch (August 2012) for the Practice Guideline for the Treatment of Patients with Eating Disorders. 3rd edition. Washington, DC: American Psychiatric Association Press, 2014.
08: Barakat S, McLean SA, Bryant E, et al. Risk factors for eating disorders: findings from a rapid review. Journal of eating disorders 2023;11(1):8. PMID 36650572
09: Bemporad JR. Cultural and historical aspects of eating disorders. Theor Med 1997;18(4):401-20. PMID 9383979
10: Bhattacharya A, DeFillipp L, Timko CA. Feeding and eating disorders. Handb Clin Neurol 2020;175:387-403. PMID 33008539
11: Brown TA, Keel PK. Eating disorders in boys and men. Ann Rev Clin Pychol 2023;19:177-205. PMID 36737595
12: Buhren K. 3.14 Nutritional rehabilitation in eating disorders. World Rev Nutr Diet 2022;124:315-20. PMID 35240633
13: Bulik CM, Reba L, Siega-Riz AM, Reichborn-Kjennerud T. Anorexia nervosa: definition, epidemiology, and cycle of risk. Int J Eat Disord 2005;37 Suppl:S2-9. PMID 15852310
14: Carpita B, Muti D, Cremone IM, Fagiolini A, Dell'Osso L. Eating disorders and autism spectrum: links and risks. CNS spectrums 2022;27:272-80. PMID 33161925
15: Eddy KT, Harshman SG, Becker KR, et al. Radcliffe ARFID Workgroup: Toward operationalization of research diagnostic criteria and directions for the field. Int J Eat Disord 2019;52(4):361-6. PMID 30758864
16: Eviatar Z, Latzer Y, Vicksman P. Anomalous lateral dominance patterns in women with eating disorders: clues to neurobiological basis. Int J Neurosci 2008;118(10):1425-42. PMID 18788027
17: Gibson D, Workman C, Mehler PS. Medical complications of anorexia nervosa and bulimia nervosa. Psychiatr Clin North Am 2019;42(2):263-74. PMID 31046928
18: Gull WW. Anorexia nervosa. Reprinted in: Kaufman MR, Herman M, editors. Evolution of Psychosomatic Concepts, 1873. New York: International Universities Press, 1964:132-6.
19: Haines J, Neumark-Sztainer D. Prevention of obesity and eating disorders: a consideration of shared risk factors. Health Educ Res 2006;21(6):770-82. PMID 16963727
20: Hartmann AS. Pica behaviors in a German community-based online adolescent and adult sample: an examination of substances, triggers, and associated pathology. Eat Weight Disord 2020;25:811-5. PMID 31016612
21: Hay P, Girosi F, Mond J. Prevalence and sociodemographic correlates of DSM-5 eating disorders in the Australian population. J Eat Disord 2015;3:19. PMID 25914826
22: Heuft L, Voigt J, Selig L, Stumvoll M, Schlogl H, Kaiser T. Refeeding syndrome. Dtsch Arztebl Int 2023;120(7):107-14. PMID 36482748
23: Hilbert A. Binge-eating disorder. Psychiatr Clin North Am 2019;42(1):33-43. PMID 30704638
24: Hornberger LL, Lane MA, Committee On Adolescence. Identification and management of eating disorders in children and adolescents. Pediatrics 2021;147(1):e2020040279. PMID 33386343
25: Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007;61(3):348-58. PMID 16815322
26: Javaras KN, Runfola CD, Thornton LM, et al. Sex- and age-specific incidence of healthcare-register-recorded eating disorders in the complete swedish 1979-2001 birth cohort. Int J Eat Disord 2015;48(8):1070-81. PMID 26769444
27: Kalindjian N, Hirot F, Stona AC, Huas C, Godart N. Early detection of eating disorders: a scoping review. Eat Weight Disord 2022;27(1):21-68. PMID 33755937
28: Katzman DK. Medical complications in adolescents with anorexia nervosa: a review of the literature. Int J Eat Disord 2005;37 Suppl:S52-9. PMID 15852321
29: Kaye W. Neurobiology of anorexia and bulimia nervosa. Physiol Behav 2008;94(1):121-35. PMID 18164737
30: Kershenbaum A, Jaffa T, Zeman A, Boniface S. Bilateral foot-drop in a patient with anorexia nervosa. Int J Eat Disord 1997;22(3):335-7. PMID 9285272
31: Kessler RC, Berglund PA, Chiu WT, et al. The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys. Biol Psychiatry 2013;73(9):904-14. PMID 23290497
32: Kessler RM, Hutson PH, Herman BK, Potenza MN. The neurobiological basis of binge-eating disorder. Neurosci Biobehav Rev 2016;63:223-38. PMID 26850211
33: Koreshe E, Paxton S, Miskovic-Wheatley J, et al. Prevention and early intervention in eating disorders: findings from a rapid review. J Eat Disord 2023;11(1):38. PMID 36899428
34: Kumar N. Neurologic presentations of nutritional deficiencies. Neurologic Clin 2010;28(1):107-70. PMID 19932379
35: Lasegue EC. On hysterical anorexia. Reprinted in: Kaufman MR, Herman M, editors. Evolution of Psychosomatic Concepts, 1873. New York: International Universities Press, 1964:143-55.
36: Lask B, Gordon I, Christie D, Frampton I, Chowdhury U, Watkins B. Functional neuroimaging in early-onset anorexia nervosa. Int J Eat Disord 2005;37 Suppl:S49-51. PMID 15852320
37: Lemly DC, Dreier MJ, Birnbaum S, Eddy KT, Thomas JJ. Caring for adults with eating disorders in primary care. Prim Care Companion CNS Disord 2022;24(1):20nr02887. PMID 34991183
38: Litmanen J, Frojd S, Marttunen M, Isomaa R, Kaltiala-Heino R. Are eating disorders and their symptoms increasing in prevalence among adolescent population? Nord J Psychiatry 2017;71(1):61-6. PMID 27626363
39: Luca A, Luca M, Calandra C. Eating disorders in late-life. Aging Dis 2015;6(1):48-55. PMID 25657852
40: Lutte I, Rhys C, Hubert C, et al. Peroneal nerve palsy in anorexia nervosa. Acta Neurol Belg 1997;97(4):251-4. PMID 9478264
41: MacKenzie JR, LaBan MM, Sackeyfio AH. The prevalence of peripheral neuropathy in patients with anorexia nervosa. Arch Phys Med Rehabil 1989;70(12):827-30. PMID 2554847
42: McLoughlin DM, Spargo E, Wassif WS, et al. Structural and functional changes in skeletal muscle in anorexia nervosa. Acta Neuropathol (Berl) 1998;95(6):632-40.
43: Mellowspring A. Eating disorders in the primary care setting. Prim Care 2023;50(1):103-17. PMID 36822720
44: Micali N, Hagberg KW, Petersen I, Treasure JL. The incidence of eating disorders in the UK in 2000-2009: findings from the General Practice Research Database. BMJ Open 2013;3(5):e002646. PMID 23793681
45: Miwa H, Nakanishi I, Kodama R, Kondo T. Cerebellar atrophy in a patient with anorexia nervosa. Int J Eat Disord 2004;36(2):238-41. PMID 15282696
46: Monteleone AM, Pellegrino F, Croatto G, et al. Treatment of eating disorders: A systematic meta-review of meta-analyses and network meta-analyses. Neurosci Biobehav Rev 2022;142:104857. PMID 36084848
47: Monteleone P, Castaldo E, Maj M. Neuroendocrine dysregulation of food intake in eating disorders. Regul Pept 2008;149(1-3):39-50. PMID 18582958
48: Muhlau M, Gaser C, Ilg R, et al. Gray matter decrease in the anterior cingulate cortex in anorexia nervosa. Am J Psychiatry 2007;164(12):1850-7. PMID 18056240
49: Muratore AF, Attia E. Current therapeutic approaches to anorexia nervosa: state of the art. Clin Ther 2021;43(1):85-94. PMID 33293054
50: Nagy H, Paul T, Jain E, et al. A clinical overview of anorexia nervosa and overcoming treatment resistance. Avicenna J Med 2023;13(1):3-14. PMID 36969350
51: National Institute of Mental Health. Eating Disorders: Facts about Eating Disorders and the Search for Solutions. NIH Publication Number 01-4901. Bethesda: National Institute of Mental Health, National Institutes of Health, US Department of Health and Human Services, 2001.
52: Nazar BP, Suwwan R, de Sousa Pinna CM, et al. Influence of attention-deficit/hyperactivity disorder on binge eating behaviors and psychiatric comorbidity profile of obese women. Compr Psychiatry 2014;55(3):572-8. PMID 24246603
53: Palla B, Litt IF. Medical complications of eating disorders in adolescents. Pediatrics 1988;81(5):613-23. PMID 3162764
54: Patchell RA, Fellows HA, Humphries LL. Neurologic complications of anorexia nervosa. Acta Neurol Scand 1994;89(2):111-6. PMID 8191873
55: Robinson P, Rhys Jones W. MARSIPAN: management of really sick patients with anorexia nervosa. BJPsych Advances 2018;24(1):20-32.
56: Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurology 2007;6:442-455.
57: Silen Y, Keski-Rahkonen A. Worldwide prevalence of DSM-5 eating disorders among young people. Curr Opin Psychiatry 2022;35(6):362-71. PMID 36125216
58: Singer C, Lorenzo D, Papapetropoulos S, Mesa A, Bowen B. Pontine/extrapontine myelinolysis occurring in the setting of an eating disorder. Neurology 2005;64(12):2156-7. PMID 15985600
59: Singleton C, Kenny TE, Hallett D, Carter JC. Depression partially mediates the association between binge eating disorder and health-related quality of life. Front Psychol 2019;10:209. PMID 30863331
60: Smink FR, van Hoeken D, Donker GA, Susser ES, Oldehinkel AJ, Hoek HW. Three decades of eating disorders in Dutch primary care: decreasing incidence of bulimia nervosa but not of anorexia nervosa. Psychol Med 2016;46(6):1189-96. PMID 26671456
61: Sonneville KR, Calzo JP, Horton NJ, et al. Childhood hyperactivity/inattention and eating disturbances predict binge eating in adolescence. Psychol Med 2015;45(12):2511-20. PMID 26098685
62: Stamatakis EA, Hetherington MM. Neuroimaging in eating disorders. Nutr Neurosci 2003;6(6):325-34. PMID 14744036
63: Stunkard AJ. Eating patterns and obesity. Psychiatric Quarterly 1959;33:284-95. PMID 13835451
64: Takano A, Shiga T, Kitagawa N, et al. Abnormal neuronal network in anorexia nervosa studied with I-123-IMP SPECT. Psychiatry Res 2001;107(1):45-50. PMID 11472863
65: Tao H, Kitagawa N, Kako Y, et al. A case of anorexia nervosa with Marchiafava-Bignami Disease that responded to high-dose intravenous corticosteroid administration. Psychiatry Res 2007;156:181-184.
66: Tolle V, Ramoz N, Epelbaum J. Is there a hypothalamic basis for anorexia nervosa? Handb Clin Neurol 2021;181:405-24. PMID 34238474
67: Treasure J, Zipfel S, Micali N, et al. Anorexia nervosa. Nature Reviews Disease Primers 2015;1:15074. PMID 27189821
68: Treasure J, Duarte TA, Schmidt U. Eating disorders. Lancet 2020;395(10227):899-911. PMID 32171414
69: Udo T, Grilo CM. Psychiatric and medical correlates of DSM-5 eating disorders in a nationally representative sample of adults in the United States. International Journal of Eating Disorders 2019;52(1):42-50. PMID 30756422
70: Udo T, Grilo CM. Epidemiology of eating disorders among US adults. Curr Opin Psychiatry 2022;35:372-8. PMID 35855509
71: Uher R, Brammer MJ, Murphy T, et al. Recovery and chronicity in anorexia nervosa: brain activity associated with differential outcomes. Biol Psychiatry 2003;54(9):934-42. PMID 14573322
72: Uniacke B, Walsh BT. Eating disorders. Ann Intern Med 2022;175(8):ITC113-28. PMID 35939813
73: Voderholzer U, Haas V, Correll CU, Korner T. Medical management of eating disorders: an update. Curr Opin Psychiatry 2020;33(6):542-53. PMID 32925184
74: Wade TD. Recent research on bulimia nervosa. Psychiatr Clin North Am 2019;42(1):21-32. PMID 30704637
75: Wagner A, Greer P, Bailer UF, et al. Normal brain tissue volumes after long-term recovery in anorexia and bulimia nervosa. Biol Psychiatry 2006;59(3):291-3. PMID 16139807
76: Zipfel S, Giel KE, Bulik CM, Hay P, Schmidt U. Anorexia nervosa: aetiology, assessment, and treatment. Lancet Psychiatry 2015;2(12):1099-111. PMID 26514083

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Neeraj Kumar MD

Dr. Kumar of the Mayo Clinic and the Mayo College of Medicine has no relevant financial relationships to disclose.
See Profile

Editor

Amy A Pruitt MD

Dr. Pruitt of the University of Pennsylvania School of Medicine has no relevant financial relationships to disclose.
See Profile

Former Authors

Christina Mueller MD and Zachary N London MD

Patient Profile

Age range of presentation: 6 to 64 years
Sex preponderance: Female > Male, > 2:1
Heredity: heredity may be a factor

heredity typical
Population groups selectively affected: None selectively affected
Occupation groups selectively affected: Athletes, including runners, ballerinas, wrestlers

ICD & OMIM codes

ICD-9: Anorexia nervosa: 307.10

Bulimia nervosa: 307.51
ICD-10: Anorexia nervosa: F50.0

Bulimia nervosa: F50.2

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Eating disorders: neurologic manifestations

Associated Disorders

Anorexia nervosa
Bulimia nervosa
Eating disorder not otherwise specified
Binge-eating disorder

Differential Diagnosis

Anorexia nervosa
Bulimia nervosa
Eating disorder not otherwise specified
Binge-eating disorder
Medical illness causing weight loss
- Other mental illness such as depressive disorders, somatization disorder, psychotic disorders
- Neurologic disease including epileptic seizures, central nervous system tumors, Kluver-Bucy syndrome, Kleine-Levin syndrome
- Sleep-related eating disorder
- Body dysmorphic disorder

	• Anorexia nervosa
	• Bulimia nervosa
	• Binge eating disorder
	• Avoidant-restrictive food intake disorder
	• Pica
	• Rumination disorder
	• Medical illnesses causing weight loss, in particular inflammatory bowel disease, thyrotoxicosis, diabetes mellitus, and systemic malignancies
	• A broad range of psychiatric and neurodevelopmental disorders
	• Neurologic disorders like epilepsy, brain tumor, Kluver-Bucy syndrome, Kleine-Levin syndrome
	• Sleep-related eating disorder
	• Body dysmorphic disorder

Eating disorders: neurologic manifestations …

Eating disorders: neurologic manifestations

Introduction

Overview

Historical note and terminology

Clinical manifestations

Presentation and course

Table 1. DSM-IV-TR Diagnostic Criteria for Anorexia Nervosa

Table 2. DSM-5 Diagnostic Criteria for Bulimia Nervosa

Table 3. DSM-5 Diagnostic Criteria for Binge-Eating Disorder

Table 4. DSM-5 Diagnostic Criteria for Avoidant-Restrictive Food Intake Disorder

Table 5. DSM-5 Diagnostic Criteria for Pica

Table 6. DSM-5 Diagnostic Criteria for Rumination Disorder

Table 7. Neurologic Dysfunction in Eating Disorders

Prognosis and complications

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Brain death/death by neurologic criteria

Hepatic encephalopathy

Bowel dysfunction in neurologic disorders

Coma due to primary brainstem and diencephalic lesions

Transient visual loss

Neuroimaging in acute stroke

Sports activities: neurologic complications

Neurotechnology: brain-computer and brain-machine interfaces

Eating disorders: neurologic manifestations

Introduction

Overview

Historical note and terminology

Clinical manifestations

Presentation and course

Table 1. DSM-IV-TR Diagnostic Criteria for Anorexia Nervosa

Table 2. DSM-5 Diagnostic Criteria for Bulimia Nervosa

Table 3. DSM-5 Diagnostic Criteria for Binge-Eating Disorder

Table 4. DSM-5 Diagnostic Criteria for Avoidant-Restrictive Food Intake Disorder

Table 5. DSM-5 Diagnostic Criteria for Pica

Table 6. DSM-5 Diagnostic Criteria for Rumination Disorder

Table 7. Neurologic Dysfunction in Eating Disorders

Prognosis and complications

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Brain death/death by neurologic criteria

Hepatic encephalopathy

Bowel dysfunction in neurologic disorders

Coma due to primary brainstem and diencephalic lesions

Transient visual loss

Neuroimaging in acute stroke

Sports activities: neurologic complications

Neurotechnology: brain-computer and brain-machine interfaces

This is an article preview.
Start a Free Account
to access the full version.